Formation Bio Secures $372 Million Series D Funding for AI-Driven Drug Development
Formation Bio, an AI-native pharmaceutical company, has raised $372 million in Series D financing, led by a16z and Sanofi. Additional …
News
Evaxion Biotech Receives Positive Feedback on Patent Application for Personalized Vaccine Targets
Evaxion Biotech A/S, a clinical-stage TechBio company known for its AI-Immunology™ powered vaccines, has received favorable feedback regarding its recent …
EvolutionaryScale Unveils ESM3 Generative AI Model for Advanced Protein Design
EvolutionaryScale has introduced its latest generative AI model, ESM3, which leverages NVIDIA H100 GPUs to enhance protein research and discovery. …
Cromatic Launches AI-Powered 'Sourcerer' for Streamlined R&D Outsourcing in Life Sciences
Cromatic, a startup focused on life sciences research outsourcing, has introduced an AI-powered tool named Sourcerer. This tool is designed …
Basecamp Research Introduces ZymCTRL: An Open-Source AI Tool for Enzyme Design
Basecamp Research, in collaboration with the Ferruz Laboratory at the Institute of Molecular Biology of Barcelona, has introduced ZymCTRL, an …
Enveda Biosciences Secures $55 Million to Accelerate Drug Discovery Efforts
Enveda Biosciences has successfully raised $55 million in a Series B2 financing round, bringing its total capital raised to $230 …
Yonalink Completes Largest EHR-to-EDC Data Transfer Pilot in Clinical Trials
Yonalink, a Boston-based provider of EHR-to-EDC streaming solutions for clinical trials, has announced the successful completion of its largest live …
Santa Ana Bio Secures $168 Million to Propel Precision Medicine for Inflammatory Diseases
Santa Ana Bio, a precision immunology company focused on developing targeted therapies for autoimmune and inflammatory diseases, has officially launched …
QuantumPharm (XtalPi) Begins Trading on Hong Kong Stock Exchange
QuantumPharm, operating as XtalPi, an AI-driven drug research company from China, commenced trading on the Hong Kong Stock Exchange on …
Cytomos Launches Benchtop Cell Analyzer
Cytomos has introduced Celledonia, a benchtop cell analyzer that promises to transform bioprocessing by delivering near real-time, cell-specific insights. Utilizing …
Lantern Pharma Receives Japanese Patent for Oncology Drug Candidate LP-284
Lantern Pharma Inc., an AI-driven company focused on oncology drug development, has announced that the Japan Patent Office (JPO) has granted …
Lokavant Introduces AI Solution for Comprehensive Clinical Trial Optimization
Lokavant has unveiled Spectrum, an AI software solution designed to enhance clinical trial feasibility and optimization throughout the entire clinical …